Untersuchung zur Real-World Versorgung von Patient*innen mit feuchter altersbedingter Makuladegeneration und diabetischem Makulaödem

5-year global, noninterventional, multinational, multicentre study designed to evaluate the real-world effectiveness and safety of products approved for retinal indications

Eudra-CT: 2020-001313-20 Phase IIIb A global, multicenter, randomized, visual assessor−masked study of the efficacy, safety, and pharmacokinetics of port delivery system with IMP in patients with macular degeneration

"Eine nicht-interventionelle, multizentrische Studie zur Untersuchung von Wirksamkeit, Sicherheit und Lebensqualität bei nAMD Switch-Patienten, die mit FARICIMAB unter Real-World-Bedingungen in Deutschland behandelt werden"

A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (PORTAL) GR40549